2001
Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users: A 10-Year Perspective
Strathdee S, Galai N, Safaiean M, Celentano D, Vlahov D, Johnson L, Nelson K. Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users: A 10-Year Perspective. JAMA Internal Medicine 2001, 161: 1281-1288. PMID: 11371255, DOI: 10.1001/archinte.161.10.1281.Peer-Reviewed Original ResearchConceptsInjection drug usersIncidence of HIVHIV seroconversionRisk factorsProspective studyDrug usersHigh-risk heterosexual activityHuman immunodeficiency virus interventionsHIV-negative injection drug usersHuman immunodeficiency virus (HIV) infectionFemale injection drug usersImmunodeficiency virus infectionInjection drug useDrug-related risksHomosexual activityTime-dependent covariatesHIV testMedian agePerson yearsDaily injectionsNeedle sharingCocaine injectionHIV riskVirus infectionSeroconversion
2000
The prevalence of homelessness among injection drug users with and without HIV infection
Song J, Safaeian M, Strathdee S, Vlahov D, Celentano D. The prevalence of homelessness among injection drug users with and without HIV infection. Journal Of Urban Health 2000, 77: 678-687. PMID: 11194310, PMCID: PMC3456762, DOI: 10.1007/bf02344031.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusInjection drug usersInjection drug useIndependent predictorsDrug usersDrug useActive injection drug useLongitudinal cohort studyCross-sectional studyHIV/AIDSCross-sectional investigationHIV seroconversionCohort studyHIV seroprevalenceHIV infectionPrevalence of homelessnessImmunodeficiency virusMale sexLogistic regressionPrevalenceParticipantsMore experiencePredictorsSeroconversionSerostatus
1999
Pre-AIDS Mortality and Morbidity among Injection Drug Users in Amsterdam and Baltimore: An Ecological Comparison
van Ameijden E, Krol A, Vlahov D, Flynn C, van Haastrecht H, Coutinho R. Pre-AIDS Mortality and Morbidity among Injection Drug Users in Amsterdam and Baltimore: An Ecological Comparison. Substance Use & Misuse 1999, 34: 845-865. PMID: 10227114, DOI: 10.3109/10826089909037245.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmphetaminesBaltimoreCause of DeathCocaineCohort StudiesComorbidityCost ControlCross-Cultural ComparisonDrug OverdoseEthanolFemaleHealth Services AccessibilityHeroinHIV SeropositivityHospitalizationHumansMaleMethadoneNetherlandsRisk FactorsSubstance Abuse, IntravenousSuicideSurvival RateUnited StatesConceptsDrug usersHigh-dose methadone maintenanceIncidence of hospitalizationSuicide mortalityEmergency room visitsInjection drug usersDifferent health care systemsHealth care systemHIV seropositivityRoom visitsHospital visitsMethadone maintenancePrimary careRecent injectingRisk factorsAIDS mortalityLower mortalityPolydrug useMortalityCare systemSocietal costsMorbidityVisitsHospitalizationBaltimoreNew evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users
Krol A, Flynn C, Vlahov D, Miedema F, Coutinho R, van Ameijden E. New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. Drug And Alcohol Dependence 1999, 54: 145-154. PMID: 10217554, DOI: 10.1016/s0376-8716(98)00158-6.Peer-Reviewed Original Research
1997
Update on the Seroepidemiology of Human Immunodeficiency Virus in the United States Household Population
McQuillan G, Khare M, Karon* J, Schable† C, Vlahov‡ D. Update on the Seroepidemiology of Human Immunodeficiency Virus in the United States Household Population. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1997, 14: 355-357. PMID: 9111478, DOI: 10.1097/00042560-199704010-00008.Peer-Reviewed Original ResearchConceptsYears of ageHIV infectionBlack men 40Human immunodeficiency virusNutrition Examination SurveyThird National HealthEstimates of seroprevalenceAnalysis of nonresponseNHANES III estimateBlack womenUnited States household populationMen 40HIV prevalenceImmunodeficiency virusExamination SurveyOverall prevalenceNational HealthHigh riskIndividuals 18Drug useHIVInfectionConfidence intervalsHousehold populationPrevalence
1996
The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study
Latkin C, Mandell W, Vlahov D. The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug And Alcohol Dependence 1996, 42: 175-181. PMID: 8912800, DOI: 10.1016/s0376-8716(96)01279-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismBlack or African AmericanComorbidityCrack CocaineFemaleFollow-Up StudiesHealth Knowledge, Attitudes, PracticeHeroin DependenceHIV InfectionsHumansMaleOpioid-Related DisordersPeer GroupProspective StudiesRisk FactorsSexual BehaviorSocial FacilitationSocial SupportSubstance Abuse, IntravenousConceptsInjection drug usersSexual risk behaviorsRisk behaviorsAlcohol consumptionDrug usersInner-city injection drug usersSex partnersAdult injection drug usersAlcohol useHIV preventive interventionsMultiple sex partnersSexual behaviorCrack cocaine useCasual sex partnersSelf-reported sexual behaviorSelf-reported drugProspective studyIndex participantsNontreatment sampleSocial contextProspective associationsPreventive interventionsCocaine useAfrican American malesInfluence of peers
1995
Correlates of Hepatitis C Virus Infections among Injection Drug Users
Thomas D, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson K. Correlates of Hepatitis C Virus Infections among Injection Drug Users. Medicine 1995, 74: 212-220. PMID: 7623656, DOI: 10.1097/00005792-199507000-00005.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis C virus infectionC virus infectionHuman immunodeficiency virusHCV infectionDrug usersVirus infectionMajority of HCVYears of injectingLong-term drug usersHCV RNASerologic evidenceImmunodeficiency virusBloodborne pathogensInjection drugsViral persistenceImmune responsePersistent infectionHigh riskHCVDrug useBiologic basisStudy participantsInfectionIllicit drugs
1994
HIV seroconversion studies among intravenous drug users
Vlahov D. HIV seroconversion studies among intravenous drug users. AIDS 1994, 8: 263-266. PMID: 8043233, DOI: 10.1097/00002030-199402000-00016.Peer-Reviewed Original Research